Your browser doesn't support javascript.
loading
Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress.
Krzemien, Pawel; Kasperczyk, Slawomir; Banach, Maciej; Kasperczyk, Aleksandra; Dobrakowski, Michal; Tomasik, Tomasz; Windak, Adam; Mastej, Miroslaw; Catapano, Alberico; Ray, Kausik K; Mikhailidis, Dimitri P; Toth, Peter P; Howard, George; Lip, Gregory Yh; Tomaszewski, Maciej; Charchar, Fadi J; Sattar, Naveed; Williams, Bryan; MacDonald, Thomas M; Penson, Peter E; Józwiak, Jacek J.
Afiliação
  • Krzemien P; Euroimmun Polska Sp. z o.o., Wroclaw, Poland.
  • Kasperczyk S; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Banach M; Department of Hypertension, Medical University of Lodz, Lódz, Poland.
  • Kasperczyk A; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Dobrakowski M; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Tomasik T; Department of Family Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Windak A; Department of Family Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Mastej M; Mastej Medical Center, Jaslo, Poland.
  • Catapano A; Department of Pharmacological Sciences, University of Milano and Multimedica IRCCS, Milano, Italy.
  • Ray KK; Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College, Kensington, London, UK.
  • Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Hospital, University College London, London, UK.
  • Toth PP; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Howard G; CGH Medical Center, Sterling, IL, USA.
  • Lip GY; Department of Biostatistics, School of Public Health of Alabama at Birmingham, Birmingham, AL, USA.
  • Tomaszewski M; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
  • Charchar FJ; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Sattar N; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Williams B; School of Health and Life Sciences, Federation University Australia, Ballarat, VIC, Australia.
  • MacDonald TM; Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.
  • Penson PE; NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
  • Józwiak JJ; MEMO Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Biomark Insights ; 17: 11772719211066791, 2022.
Article em En | MEDLINE | ID: mdl-35125863
BACKGROUND: The anti-DFS70 autoantibodies are one of the most commonly and widely described agent of unknown clinical significance, frequently detected in healthy individuals. It is not known whether the DFS70 autoantibodies are protective or pathogenic. One of the factors suspected of inducing the formation of anti-DFS70 antibodies is increased oxidative stress. We evaluated the coexistence of anti-DFS70 antibodies with selected markers of oxidative stress and investigated whether these antibodies could be considered as indirect markers of oxidative stress. METHODS: The intensity of oxidative stress was measured in all samples via indices of free-radical damage to lipids and proteins such as total oxidant status (TOS), concentrations of lipid hydroperoxides (LPH), lipofuscin (LPS), and malondialdehyde (MDA). The parameters of the non-enzymatic antioxidant system, such as total antioxidant status (TAS) and uric acid concentration (UA), were also measured, as well as the activity of superoxide dismutase (SOD). Based on TOS and TAS values, the oxidative stress index (OSI) was calculated. All samples were also tested with indirect immunofluorescence assay (IFA) and 357 samples were selected for direct monospecific anti DFS70 enzyme-linked immunosorbent assay (ELISA) testing. RESULTS: The anti-DFS70 antibodies were confirmed by ELISA test in 21.29% of samples. Compared with anti-DFS70 negative samples we observed 23% lower concentration of LPH (P = .038) and 11% lower concentration of UA (P = .005). TOS was 20% lower (P = .014). The activity of SOD was up to 5% higher (P = .037). The Pearson correlation showed weak negative correlation for LPH, UA, and TOS and a weak positive correlation for SOD activity. CONCLUSION: In samples positive for the anti-DFS70 antibody a decreased level of oxidative stress was observed, especially in the case of samples with a high antibody titer. Anti-DFS70 antibodies can be considered as an indirect marker of reduced oxidative stress or a marker indicating the recent intensification of antioxidant processes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article